These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 36194668)

  • 1. miR-181a/b downregulation: a mutation-independent therapeutic approach for inherited retinal diseases.
    Carrella S; Di Guida M; Brillante S; Piccolo D; Ciampi L; Guadagnino I; Garcia Piqueras J; Pizzo M; Marrocco E; Molinari M; Petrogiannakis G; Barbato S; Ezhova Y; Auricchio A; Franco B; De Leonibus E; Surace EM; Indrieri A; Banfi S
    EMBO Mol Med; 2022 Nov; 14(11):e15941. PubMed ID: 36194668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AAV-miR-204 Protects from Retinal Degeneration by Attenuation of Microglia Activation and Photoreceptor Cell Death.
    Karali M; Guadagnino I; Marrocco E; De Cegli R; Carissimo A; Pizzo M; Casarosa S; Conte I; Surace EM; Banfi S
    Mol Ther Nucleic Acids; 2020 Mar; 19():144-156. PubMed ID: 31837604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting miR-181a/b in retinitis pigmentosa: implications for disease progression and therapy.
    Costa BLD; Quinn PMJ; Wu WH; Liu S; Nolan ND; Demirkol A; Tsai YT; Caruso SM; Cabral T; Wang NK; Tsang SH
    Cell Biosci; 2024 May; 14(1):64. PubMed ID: 38773556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-181a/b downregulation exerts a protective action on mitochondrial disease models.
    Indrieri A; Carrella S; Romano A; Spaziano A; Marrocco E; Fernandez-Vizarra E; Barbato S; Pizzo M; Ezhova Y; Golia FM; Ciampi L; Tammaro R; Henao-Mejia J; Williams A; Flavell RA; De Leonibus E; Zeviani M; Surace EM; Banfi S; Franco B
    EMBO Mol Med; 2019 May; 11(5):. PubMed ID: 30979712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy for inherited retinal diseases: progress and possibilities.
    Hu ML; Edwards TL; O'Hare F; Hickey DG; Wang JH; Liu Z; Ayton LN
    Clin Exp Optom; 2021 May; 104(4):444-454. PubMed ID: 33689657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wheel running exercise protects against retinal degeneration in the I307N rhodopsin mouse model of inducible autosomal dominant retinitis pigmentosa.
    Zhang X; Girardot PE; Sellers JT; Li Y; Wang J; Chrenek MA; Wu W; Skelton H; Nickerson JM; Pardue MT; Boatright JH
    Mol Vis; 2019; 25():462-476. PubMed ID: 31523123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome Editing as a Treatment for the Most Prevalent Causative Genes of Autosomal Dominant Retinitis Pigmentosa.
    Diakatou M; Manes G; Bocquet B; Meunier I; Kalatzis V
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31126147
    [No Abstract]   [Full Text] [Related]  

  • 8. Mesenchymal stem cell-derived extracellular vesicles protect retina in a mouse model of retinitis pigmentosa by anti-inflammation through miR-146a-Nr4a3 axis.
    Zhang J; Li P; Zhao G; He S; Xu D; Jiang W; Peng Q; Li Z; Xie Z; Zhang H; Xu Y; Qi L
    Stem Cell Res Ther; 2022 Aug; 13(1):394. PubMed ID: 35922863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation-independent rhodopsin gene therapy by knockdown and replacement with a single AAV vector.
    Cideciyan AV; Sudharsan R; Dufour VL; Massengill MT; Iwabe S; Swider M; Lisi B; Sumaroka A; Marinho LF; Appelbaum T; Rossmiller B; Hauswirth WW; Jacobson SG; Lewin AS; Aguirre GD; Beltran WA
    Proc Natl Acad Sci U S A; 2018 Sep; 115(36):E8547-E8556. PubMed ID: 30127005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bardet-Biedl Syndrome in rhesus macaques: A nonhuman primate model of retinitis pigmentosa.
    Peterson SM; McGill TJ; Puthussery T; Stoddard J; Renner L; Lewis AD; Colgin LMA; Gayet J; Wang X; Prongay K; Cullin C; Dozier BL; Ferguson B; Neuringer M
    Exp Eye Res; 2019 Dec; 189():107825. PubMed ID: 31589838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A common microRNA signature in mouse models of retinal degeneration.
    Loscher CJ; Hokamp K; Wilson JH; Li T; Humphries P; Farrar GJ; Palfi A
    Exp Eye Res; 2008 Dec; 87(6):529-34. PubMed ID: 18834879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term preservation of cone photoreceptors and visual acuity in rd10 mutant mice exposed to continuous environmental enrichment.
    Barone I; Novelli E; Strettoi E
    Mol Vis; 2014; 20():1545-56. PubMed ID: 25489227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review: the history and role of naturally occurring mouse models with Pde6b mutations.
    Han J; Dinculescu A; Dai X; Du W; Smith WC; Pang J
    Mol Vis; 2013 Dec; 19():2579-89. PubMed ID: 24367157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered retinal microRNA expression profile in a mouse model of retinitis pigmentosa.
    Loscher CJ; Hokamp K; Kenna PF; Ivens AC; Humphries P; Palfi A; Farrar GJ
    Genome Biol; 2007; 8(11):R248. PubMed ID: 18034880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of MicroRNA 6937 Delays Photoreceptor and Vision Loss in a Mouse Model of Retinitis Pigmentosa.
    Anasagasti A; Lara-López A; Milla-Navarro S; Escudero-Arrarás L; Rodríguez-Hidalgo M; Zabaleta N; González Aseguinolaza G; de la Villa P; Ruiz-Ederra J
    Pharmaceutics; 2020 Sep; 12(10):. PubMed ID: 32987664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term rescue of cone photoreceptor degeneration in retinitis pigmentosa 2 (RP2)-knockout mice by gene replacement therapy.
    Mookherjee S; Hiriyanna S; Kaneshiro K; Li L; Li Y; Li W; Qian H; Li T; Khanna H; Colosi P; Swaroop A; Wu Z
    Hum Mol Genet; 2015 Nov; 24(22):6446-58. PubMed ID: 26358772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AAV mediated GDNF secretion from retinal glia slows down retinal degeneration in a rat model of retinitis pigmentosa.
    Dalkara D; Kolstad KD; Guerin KI; Hoffmann NV; Visel M; Klimczak RR; Schaffer DV; Flannery JG
    Mol Ther; 2011 Sep; 19(9):1602-8. PubMed ID: 21522134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal Inflammation, Cell Death and Inherited Retinal Dystrophies.
    Olivares-González L; Velasco S; Campillo I; Rodrigo R
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autosomal dominant retinitis pigmentosa with toxic gain of function: Mechanisms and therapeutics.
    Narasimhan I; Murali A; Subramanian K; Ramalingam S; Parameswaran S
    Eur J Ophthalmol; 2021 Mar; 31(2):304-320. PubMed ID: 32962414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene editing prospects for treating inherited retinal diseases.
    Benati D; Patrizi C; Recchia A
    J Med Genet; 2020 Jul; 57(7):437-444. PubMed ID: 31857428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.